‘New Era’ To Begin For UK’s ILAP In 2025, With Focus On ‘Transformative’ Drugs

Transformation origami figures
The UK wants to encourage the development of "transformative" medicines (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Agency Leadership

More from Pathways & Standards